합성생물학 시장 : 툴, 기술, 최종 용도별 - 세계 예측(2025-2030년)

The Synthetic Biology Market was valued at USD 13.88 billion in 2023, expected to reach USD 16.61 billion in 2024, and is projected to grow at a CAGR of 21.33%, to USD 53.76 billion by 2030.

Synthetic biology is an interdisciplinary field that combines elements of biology, engineering, computer science, and chemistry to design and construct new biological parts, devices, and systems or to modify existing ones for useful purposes. The necessity of synthetic biology lies in its potential to revolutionize various sectors, such as agriculture, by creating disease-resistant crops; healthcare, through engineered organisms for drug production and personalized medicine; and environmental management, by developing organisms that can break down pollutants. Its application extends to biofuel production, where engineered microbes efficiently convert biomass into energy, and the industrial sector for producing chemicals, materials, and enzymes. The end-use scope extends to academia, research institutions, and a host of commercial industries seeking innovative solutions to global challenges.

Key growth drivers for the synthetic biology market include advancements in genetic engineering technologies, increased investment in biotech research, and a rising demand for sustainable and eco-friendly solutions. The burgeoning interest in precision medicine and tailored therapies further propels market advancements. Present opportunities focus on collaborations between academic institutions and biotech firms, expansion of CRISPR technology, and the integration of artificial intelligence for improved bio-design processes. To capitalize on these, stakeholders should prioritize investments in R&D, forge strategic partnerships, and engage with policy-makers to foster conducive regulatory landscapes. However, challenges such as ethical concerns, potential biosecurity risks, and high R&D costs pose significant barriers. Market growth is also hampered by the complexities of biological systems which can result in unpredictable outcomes.

Cutting-edge innovations are being contemplated in genome synthesis, the development of biosensors for real-time monitoring, and synthetic biology's role in space exploration. Investing in scalable synthetic bio-manufacturing technologies could significantly boost economic viability. The synthetic biology market is characterized by dynamic growth, continuous innovation, and intense collaboration across disciplines. To thrive, businesses should remain adaptable, engage in ongoing dialogue with regulatory bodies, and focus on breakthroughs that address specific societal needs while ensuring ethical standards are upheld.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Synthetic Biology Market

The Synthetic Biology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use for novel drug and vaccines development
  • Expansion of synthetic biology based point-of-care diagnostics devices
  • Accelerating demand for synthetic biology in various industrial applications
• Market Restraints
  • Risks associated with the use of synthetic biology technology
• Market Opportunities
  • Technological advancements in gene editing and next generation sequencing
  • Rising R&D funding and investments for expansion of synthetic biology applications
• Market Challenges
  • Constraints of synthetic biology in modularization and standardization of biological parts

Porter's Five Forces: A Strategic Tool for Navigating the Synthetic Biology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Synthetic Biology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Synthetic Biology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Synthetic Biology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Synthetic Biology Market

A detailed market share analysis in the Synthetic Biology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Synthetic Biology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Synthetic Biology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Synthetic Biology Market

A strategic analysis of the Synthetic Biology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Tools, market is studied across DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools, Protein Tools, and RNA Tools.
• Based on Technology, market is studied across Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly, Cloning, Microfluidics, Nanotechnology, Omics Technologies, and Site-directed Mutagenesis.
• Based on End-Use, market is studied across Agriculture, Cosmetics & Personal Care, Energy & Natural Resources, Environment, Food & Beverage, Healthcare & Pharmaceuticals, and Paper & Textile. The Environment is further studied across Bioremediation and Biosensing. The Healthcare & Pharmaceuticals is further studied across Artificial Tissue & Tissue Regeneration and Drug Discovery & Therapeutics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use for novel drug and vaccines development
    • 5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
    • 5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with the use of synthetic biology technology
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in gene editing and next generation sequencing
    • 5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
  • 5.1.4. Challenges
    • 5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
• 5.2. Market Segmentation Analysis
  • 5.2.1. Tools: Exploring essential tools for powering innovations in synthetic biology
  • 5.2.2. End-Use: Rise of synthetic biology in transforming end-use industries
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Synthetic Biology Market, by Tools

• 6.1. Introduction
• 6.2. DNA Tools
• 6.3. General Tools
• 6.4. Mathematical Modelling & Computer-aided Design Tools
• 6.5. Protein Tools
• 6.6. RNA Tools

7. Synthetic Biology Market, by Technology

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Cell Sequencing
• 7.4. Cell Synthesis & Assembly
• 7.5. Cloning
• 7.6. Microfluidics
• 7.7. Nanotechnology
• 7.8. Omics Technologies
• 7.9. Site-directed Mutagenesis

8. Synthetic Biology Market, by End-Use

• 8.1. Introduction
• 8.2. Agriculture
• 8.3. Cosmetics & Personal Care
• 8.4. Energy & Natural Resources
• 8.5. Environment
  • 8.5.1. Bioremediation
  • 8.5.2. Biosensing
• 8.6. Food & Beverage
• 8.7. Healthcare & Pharmaceuticals
  • 8.7.1. Artificial Tissue & Tissue Regeneration
  • 8.7.2. Drug Discovery & Therapeutics
• 8.8. Paper & Textile

9. Americas Synthetic Biology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Synthetic Biology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Asimov and iGEM Collaborate to Nurture Future Leaders in Synthetic Biology
  • 12.3.2. NREL Partners with Leading Institutions to Accelerate Biofuel Innovations through Synthetic Biology
  • 12.3.3. Moderna Expands mRNA Capabilities with Acquisition of Japanese Genomics Firm Oriciro
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Amyris, Inc.
• 3. Arzeda
• 4. Batavia Biosciences B.V.
• 5. Beam Therapeutics
• 6. Beckman Coulter, Inc.
• 7. BGI Genomics Co., Ltd.
• 8. Codexis, Inc.
• 9. Conagen, Inc.
• 10. Creative Enzymes
• 11. DNA TwoPointO Inc.
• 12. Editas Medicine, Inc.
• 13. Eurofins Scientific
• 14. GenScript Biotech Corporation
• 15. Ginkgo Bioworks, Inc.
• 16. Illumina, Inc.
• 17. Integrated DNA Technologies, Inc.
• 18. Merck KGaA
• 19. New England Biolabs GmbH
• 20. Novozymes A/S
• 21. Precigen, Inc.
• 22. QIAGEN N.V.
• 23. Sangamo Therapeutics
• 24. Scarab Genomics, LLC
• 25. Synlogic
• 26. Synthego Corporation
• 27. TeselaGen Service
• 28. Thermo Fisher Scientific Inc.
• 29. Twist Bioscience Corporation